Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group.
COVID-19
Inflammatory bowel disease
Paediatrics
SARS-CoV2
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
03
08
2020
revised:
15
10
2020
accepted:
18
10
2020
pubmed:
3
11
2020
medline:
21
1
2021
entrez:
2
11
2020
Statut:
ppublish
Résumé
Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, spreading in Italy during the first months of 2020, abruptly changed the way of practicing medicine in this country. As a consequence of the lockdown, the diagnostic and therapeutic management of paediatric chronic conditions, such as inflammatory bowel disease (IBD) has been affected. During the peak of COVID-19 pandemic, elective visits, endoscopies and infusions have been postponed, with potential clinical and psychological impact on disease course and a high likelihood of increasing waiting lists. While slowly moving back towards normality, clinicians need to recognize the best ways to care for patients with IBD, carefully avoiding risk factors for new potential epidemic outbreaks. In this uncertain scenario until the development and spread of COVID-19 vaccine, it is necessary to continue to operate with caution. Hereby we provide useful indications for a safer and gradual restarting of routine clinical activities after COVID-19 peak in Italy.
Identifiants
pubmed: 33132063
pii: S1590-8658(20)30976-2
doi: 10.1016/j.dld.2020.10.024
pmc: PMC7580561
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
183-189Informations de copyright
Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have no conflict of interest to declare.
Références
Gastroenterology. 2020 Sep;159(3):805-808.e1
pubmed: 32474119
J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):720-726
pubmed: 32443019
Endoscopy. 2020 Jun;52(6):483-490
pubmed: 32303090
J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):257-291
pubmed: 30044357
Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S10-S20
pubmed: 29459143
Gut. 2020 Jul;69(7):1213-1217
pubmed: 32354990
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
Gastroenterology. 2020 Jul;159(1):350-357
pubmed: 32283100
Gastroenterology. 2007 Aug;133(2):423-32
pubmed: 17681163
Clinics (Sao Paulo). 2020;75:e1931
pubmed: 32401965
J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):e140
pubmed: 32443060
Inflamm Bowel Dis. 2015 Feb;21(2):392-9
pubmed: 25437818
J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):734-740
pubmed: 32443021
J Clin Virol. 2004 Dec;31(4):304-9
pubmed: 15494274
N Engl J Med. 2020 May 14;382(20):1873-1875
pubmed: 32187459
Inflamm Bowel Dis. 2020 Aug 20;26(9):1306-1314
pubmed: 32720978
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525-527
pubmed: 32311321
Gut. 2010 Dec;59(12):1652-61
pubmed: 21071584
Arch Dis Child. 2020 Dec;105(12):1186-1191
pubmed: 32732316
J Pediatr Gastroenterol Nutr. 2020 Aug;71(2):153-155
pubmed: 32452979
Inflamm Bowel Dis. 2017 Oct;23(10):1678-1681
pubmed: 28817463
Nat Rev Gastroenterol Hepatol. 2020 Aug;17(8):441-443
pubmed: 32483356
J Crohns Colitis. 2020 Sep 16;14(9):1330-1333
pubmed: 32211765
Aliment Pharmacol Ther. 2020 Jul;52(1):54-72
pubmed: 32348598
Inflamm Bowel Dis. 2012 Jan;18(1):55-62
pubmed: 21351206
Lancet Child Adolesc Health. 2020 May;4(5):346-347
pubmed: 32243784
Inflamm Bowel Dis. 2020 Aug 20;26(9):e95-e96
pubmed: 32440675
Gastroenterology. 2018 Aug;155(2):337-346.e10
pubmed: 29655835
Gut. 2012 Feb;61(2):229-34
pubmed: 21948942
Gut. 2020 Jun;69(6):984-990
pubmed: 32303607
Inflamm Bowel Dis. 2020 Feb 11;26(3):331-346
pubmed: 31504524
Inflamm Bowel Dis. 2017 Sep;23(9):1473-1482
pubmed: 28617758
J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):410-416
pubmed: 28832362
Gastroenterology. 2020 Jul;159(1):81-95
pubmed: 32251668
Am J Gastroenterol. 2019 Mar;114(3):472-482
pubmed: 30410041
Inflamm Bowel Dis. 2017 Mar;23(3):357-365
pubmed: 28221247
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24
pubmed: 22344983
J Pediatr Gastroenterol Nutr. 2002 Oct;35(4):557-63
pubmed: 12394384
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):254-260
pubmed: 27050050
Gastroenterology. 2020 Aug;159(2):481-491.e3
pubmed: 32425234
Pediatr Gastroenterol Hepatol Nutr. 2019 Jan;22(1):28-40
pubmed: 30671371
J Med Microbiol. 2003 Aug;52(Pt 8):715-720
pubmed: 12867568
Aliment Pharmacol Ther. 2020 Jul;52(2):276-283
pubmed: 32359205
Dig Dis Sci. 2007 Feb;52(2):357-64
pubmed: 17211702
Dig Liver Dis. 2020 Nov;52(11):1238-1240
pubmed: 32601025
Inflamm Bowel Dis. 2016 Sep;22(9):2158-64
pubmed: 27482979
BMJ Evid Based Med. 2019 Feb;24(1):37-38
pubmed: 30042210
United European Gastroenterol J. 2020 Aug;8(7):775-781
pubmed: 32438878
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Inflamm Bowel Dis. 2020 May 12;26(6):793-796
pubmed: 32314792
J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):727-733
pubmed: 32443020
Gastroenterology. 2010 Jun;138(7):2282-91
pubmed: 20193683
Gut. 2020 Jul;69(7):1364-1365
pubmed: 32312788
Inflamm Bowel Dis. 2018 Oct 12;24(11):2431-2441
pubmed: 30312414
Inflamm Bowel Dis. 2009 Jun;15(6):837-44
pubmed: 19107771
Clin Gastroenterol Hepatol. 2017 Nov;15(11):1742-1749.e2
pubmed: 28606846
Lancet. 2020 Mar 21;395(10228):945-947
pubmed: 32145186
Nat Rev Gastroenterol Hepatol. 2020 Aug;17(8):507-516
pubmed: 32528139
J Crohns Colitis. 2020 Oct 21;14(14 Suppl 3):S798-S806
pubmed: 32722754
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):253-255
pubmed: 32214232
Gut. 2020 Jul;69(7):1335-1342
pubmed: 32303609